Bristol-Myers Squibb Provides Update on Pending Merger with Celgene
Go back to Bristol-Myers Squibb Provides Update on Pending Merger with Celgene| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.10 -1.51 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.61 | 52 Week High | $77.12 | |||
| Open | $67.22 | 52 Week Low | $49.03 | |||
| Day High | $67.54 | P/E | 42.92 | |||
| Day Low | $66.08 | EPS | $1.54 | |||
| Volume | 4,570,296 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
